ACM Research Quarterly Balance Sheets Chart
Quarterly
|
Annual
ACM Research Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||
cash and cash equivalents | 442,088,000 | 457,240,000 | 407,445,000 | 333,472,000 | 324,031,000 | 211,305,000 | 182,090,000 | 207,101,000 | 257,420,000 | 260,387,000 | 336,275,000 | 323,716,000 | 380,311,000 | 65,036,000 | 70,209,000 | 78,796,000 | 71,766,000 | 92,203,000 | 86,397,000 | 52,283,000 | 47,264,000 | 27,578,000 | 27,367,000 | 27,124,000 | 18,238,000 | 17,435,000 | 15,186,000 | 17,681,000 | 17,074,000 |
restricted cash | 10,798,000 | 10,586,000 | 3,865,000 | 1,782,000 | 881,000 | 808,000 | 1,083,000 | 560,000 | 582,000 | 460,000 | 367,000 | 628,000 | 58,726,000 | 26,582,000 | 433,000 | ||||||||||||||
short-term time deposits | 31,019,000 | 17,202,000 | 17,277,000 | 20,304,000 | 27,183,000 | 48,364,000 | 80,524,000 | 75,651,000 | 6,000,000 | 2,999,000 | 66,176,000 | 70,030,000 | 74,025,000 | ||||||||||||||||
short-term investments | 21,115,000 | 18,319,000 | 19,373,000 | 20,351,000 | 19,597,000 | 18,648,000 | 21,312,000 | 21,844,000 | |||||||||||||||||||||
account receivables | 433,662,000 | 387,045,000 | |||||||||||||||||||||||||||
other receivables | 43,708,000 | 35,050,000 | 41,859,000 | 57,849,000 | 53,694,000 | 51,316,000 | 40,065,000 | 36,126,000 | 34,491,000 | 36,178,000 | 15,135,000 | 16,208,000 | 23,602,000 | 13,165,000 | 10,733,000 | 11,216,000 | 9,679,000 | 6,177,000 | 7,651,000 | 3,236,000 | 2,152,000 | 2,388,000 | 2,982,000 | 3,547,000 | 1,591,000 | 1,308,000 | 1,222,000 | 2,491,000 | 2,017,000 |
inventories | 648,278,000 | 609,567,000 | 597,984,000 | 628,720,000 | 602,927,000 | 581,140,000 | 545,395,000 | 507,431,000 | 471,094,000 | 473,299,000 | 327,792,000 | 288,080,000 | 271,538,000 | 176,609,000 | 136,852,000 | 103,226,000 | 88,639,000 | 64,182,000 | 49,772,000 | 44,987,000 | 43,506,000 | 45,494,000 | 42,253,000 | 38,764,000 | 29,809,000 | 27,531,000 | |||
advances to related parties | 682,000 | ||||||||||||||||||||||||||||
prepaid expenses and other current assets | 14,303,000 | 10,677,000 | |||||||||||||||||||||||||||
total current assets | 1,645,653,000 | 1,547,874,000 | 1,483,379,000 | 1,445,314,000 | 1,343,162,000 | 1,229,356,000 | 1,176,110,000 | 1,115,894,000 | 996,832,000 | 993,811,000 | 971,242,000 | 900,628,000 | 904,977,000 | 377,347,000 | 329,361,000 | 286,552,000 | 260,656,000 | 251,777,000 | 205,880,000 | 198,477,000 | 163,654,000 | 108,400,000 | 99,505,000 | 96,028,000 | 82,777,000 | 81,879,000 | 66,494,000 | 62,914,000 | 56,022,000 |
property, plant and equipment | 290,944,000 | 277,065,000 | 269,272,000 | 250,099,000 | 228,731,000 | 218,822,000 | 201,848,000 | 190,882,000 | 159,013,000 | 149,904,000 | 66,470,000 | 57,266,000 | 57,680,000 | 10,005,000 | 8,985,000 | 8,772,000 | 8,192,000 | 5,974,000 | 3,956,000 | 3,495,000 | 3,573,000 | 3,376,000 | 3,719,000 | 3,708,000 | 3,593,000 | 3,050,000 | 2,731,000 | 2,340,000 | 2,346,000 |
operating lease right-of-use assets | 17,285,000 | 17,747,000 | 14,038,000 | 5,680,000 | 6,252,000 | 6,498,000 | 7,026,000 | 7,184,000 | 7,809,000 | 7,408,000 | 2,647,000 | 3,478,000 | 4,028,000 | 4,599,000 | 5,209,000 | 5,349,000 | 4,297,000 | 4,568,000 | 4,648,000 | 3,547,000 | 4,205,000 | 4,550,000 | 4,787,000 | ||||||
intangible assets | 2,849,000 | 2,997,000 | 3,461,000 | 2,838,000 | 2,836,000 | 2,803,000 | 2,538,000 | 2,163,000 | 2,107,000 | 1,233,000 | 873,000 | 661,000 | 748,000 | 556,000 | 630,000 | 602,000 | 554,000 | 335,000 | 329,000 | 307,000 | 285,000 | 307,000 | 263,000 | 274,000 | 300,000 | 231,000 | 126,000 | 106,000 | 35,000 |
long-term time deposits | 13,393,000 | 13,275,000 | 13,517,000 | 14,656,000 | 27,841,000 | 40,818,000 | 43,183,000 | 112,104,000 | 117,855,000 | 70,400,000 | 74,500,000 | 78,750,000 | |||||||||||||||||
deferred tax assets | 22,341,000 | 16,457,000 | 14,781,000 | 13,400,000 | 20,898,000 | 21,360,000 | 20,271,000 | 16,486,000 | 11,249,000 | 13,035,000 | 6,576,000 | 10,767,000 | 15,303,000 | 15,795,000 | 14,691,000 | 13,908,000 | 11,076,000 | 10,093,000 | 5,763,000 | 5,212,000 | 2,309,000 | 1,635,000 | 1,669,000 | 1,637,000 | 1,230,000 | 1,278,000 | 1,345,000 | 1,294,000 | 1,433,000 |
long-term investments | 56,723,000 | 54,814,000 | 37,063,000 | 33,655,000 | 31,898,000 | 31,293,000 | 27,880,000 | 22,306,000 | 16,122,000 | 17,265,000 | 18,538,000 | 12,612,000 | 12,666,000 | 7,408,000 | 7,006,000 | 6,632,000 | 6,340,000 | 6,580,000 | 20,360,000 | 6,015,000 | 5,968,000 | 1,738,000 | |||||||
other long-term assets | 3,920,000 | 3,421,000 | 20,452,000 | 21,352,000 | 10,917,000 | 10,471,000 | 6,050,000 | 3,851,000 | 3,388,000 | 3,479,000 | 2,373,000 | 2,520,000 | 3,559,000 | 44,243,000 | 43,434,000 | 40,475,000 | 40,496,000 | 8,008,000 | 16,466,000 | 155,000 | 222,000 | 263,000 | 40,000 | 41,000 | 40,000 | ||||
total assets | 2,039,715,000 | 1,933,768,000 | 1,855,721,000 | 1,794,175,000 | 1,667,575,000 | 1,556,749,000 | 1,490,908,000 | 1,410,248,000 | 1,316,914,000 | 1,312,751,000 | 1,147,666,000 | 1,071,524,000 | 1,087,372,000 | 469,509,000 | 418,958,000 | 371,819,000 | 341,257,000 | 296,619,000 | 257,402,000 | 217,208,000 | 180,216,000 | 120,269,000 | 111,419,000 | 103,047,000 | 89,413,000 | 87,833,000 | 71,934,000 | 67,891,000 | 61,056,000 |
liabilities and equity | |||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||
short-term borrowings | 52,969,000 | 24,951,000 | 32,814,000 | 33,795,000 | 54,439,000 | 54,706,000 | 31,335,000 | 33,911,000 | 53,976,000 | 56,745,000 | 50,688,000 | 4,898,000 | 9,600,000 | 15,201,000 | 22,162,000 | 23,490,000 | 26,147,000 | 28,327,000 | 25,772,000 | 3,892,000 | 15,665,000 | 15,110,000 | 12,829,000 | 9,447,000 | 10,163,000 | 9,932,000 | 10,376,000 | 5,095,000 | 3,472,000 |
current portion of long-term borrowings | 62,139,000 | 67,935,000 | 44,472,000 | 30,670,000 | 19,671,000 | 6,549,000 | 6,783,000 | 6,717,000 | 3,239,000 | 2,369,000 | 2,260,000 | 2,328,000 | 2,441,000 | 2,351,000 | 1,799,000 | 1,598,000 | 1,591,000 | ||||||||||||
related parties accounts payable | 19,827,000 | ||||||||||||||||||||||||||||
accounts payable | 148,780,000 | 116,441,000 | 139,294,000 | 170,810,000 | 142,418,000 | 135,499,000 | 141,814,000 | 136,675,000 | 106,861,000 | 116,558,000 | 92,325,000 | 93,902,000 | 108,494,000 | 92,825,000 | 67,031,000 | 44,721,000 | 35,603,000 | 35,639,000 | 27,986,000 | 18,616,000 | 15,440,000 | 18,238,000 | 13,333,000 | 16,673,000 | 11,991,000 | 17,755,000 | 5,525,000 | 7,419,000 | 8,667,000 |
advances from customers | 221,446,000 | 241,456,000 | 243,949,000 | 215,678,000 | 205,609,000 | 182,547,000 | 181,368,000 | 191,393,000 | 195,485,000 | 180,453,000 | 136,610,000 | 94,421,000 | 82,036,000 | 52,681,000 | 43,845,000 | 32,668,000 | 17,888,000 | 8,011,000 | 8,780,000 | 9,236,000 | 8,397,000 | 5,684,000 | 8,469,000 | 8,417,000 | 3,918,000 | 1,931,000 | 264,000 | 143,000 | 75,000 |
deferred revenue | 13,660,000 | 10,781,000 | 8,537,000 | 10,138,000 | 5,279,000 | 4,405,000 | 3,687,000 | 4,747,000 | 5,050,000 | 4,400,000 | 4,911,000 | 2,950,000 | 2,699,000 | 2,403,000 | 2,348,000 | 1,315,000 | 1,343,000 | 819,000 | 474,000 | ||||||||||
income taxes payable | 253,000 | 6,168,000 | 12,779,000 | 6,796,000 | 11,136,000 | 11,403,000 | 6,401,000 | 11,061,000 | 10,324,000 | 8,579,000 | 8,564,000 | 2,032,000 | -1,744,000 | 1,233,000 | 482,000 | 105,000 | 31,000 | 3,589,000 | 1,669,000 | 3,347,000 | 1,326,000 | 1,016,000 | 1,228,000 | 1,193,000 | 689,000 | 231,000 | 44,000 | 44,000 | |
fin-48 payable | 21,373,000 | 19,483,000 | 19,466,000 | 8,991,000 | 12,093,000 | 12,131,000 | 12,149,000 | 6,487,000 | 6,446,000 | 6,774,000 | 2,054,000 | 2,171,000 | 2,292,000 | 83,000 | 83,000 | 82,000 | 83,000 | ||||||||||||
other payables and accrued expenses | 126,787,000 | 118,814,000 | 121,657,000 | 115,388,000 | 114,940,000 | 107,098,000 | 102,951,000 | 80,400,000 | 59,997,000 | 52,966,000 | 40,281,000 | 39,195,000 | 36,555,000 | 25,950,000 | 21,871,000 | 21,885,000 | 18,805,000 | 18,494,000 | 15,357,000 | 14,331,000 | 13,970,000 | 11,993,000 | 11,834,000 | 10,410,000 | 8,090,000 | 6,518,000 | 6,542,000 | 6,026,000 | 5,264,000 |
current portion of operating lease liabilities | 3,778,000 | 3,564,000 | 2,132,000 | 2,377,000 | 2,573,000 | 2,668,000 | 2,876,000 | ||||||||||||||||||||||
total current liabilities | 671,012,000 | 628,878,000 | 641,233,000 | 610,035,000 | 586,170,000 | 533,249,000 | 500,659,000 | 481,951,000 | 456,299,000 | 450,211,000 | 345,602,000 | 252,733,000 | 244,449,000 | 195,207,000 | 162,058,000 | 128,035,000 | 102,908,000 | 96,267,000 | 96,516,000 | 50,767,000 | 56,148,000 | 53,401,000 | 49,019,000 | 46,140,000 | 34,851,000 | 36,367,000 | 22,751,000 | 21,817,000 | 20,566,000 |
long-term borrowings | 162,991,000 | 134,540,000 | 105,525,000 | 106,069,000 | 70,833,000 | 53,408,000 | 53,952,000 | 39,753,000 | 15,899,000 | 18,245,000 | 18,810,000 | 20,642,000 | 22,344,000 | 23,080,000 | 18,717,000 | 17,444,000 | 17,979,000 | ||||||||||||
long-term operating lease liabilities | 5,496,000 | 6,149,000 | 3,840,000 | 3,303,000 | 3,679,000 | 3,830,000 | 4,308,000 | ||||||||||||||||||||||
other long-term liabilities | 8,527,000 | 8,848,000 | 9,217,000 | 5,685,000 | 5,505,000 | 5,469,000 | 5,873,000 | 6,106,000 | 6,566,000 | 7,195,000 | 6,660,000 | 8,063,000 | 8,545,000 | 5,303,000 | 4,557,000 | 6,639,000 | 8,034,000 | 6,454,000 | 6,584,000 | 5,830,000 | 2,980,000 | 3,963,000 | 3,296,000 | 4,583,000 | 5,230,000 | 5,869,000 | 6,181,000 | 6,217,000 | 6,682,000 |
total liabilities | 848,026,000 | 778,415,000 | 759,815,000 | 725,092,000 | 666,187,000 | 595,956,000 | 564,746,000 | 532,118,000 | 483,531,000 | 480,046,000 | 373,568,000 | 284,379,000 | 278,598,000 | 227,002,000 | 189,402,000 | 156,572,000 | 133,087,000 | 105,901,000 | 106,417,000 | 58,799,000 | 61,983,000 | 60,554,000 | 55,777,000 | 50,723,000 | 40,081,000 | 42,236,000 | 28,932,000 | 28,034,000 | 27,248,000 |
commitments and contingencies | |||||||||||||||||||||||||||||
equity: | |||||||||||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||||||||||
class a common stock | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 5,000 | 5,000 | 5,000 | ||||||||||||||||||
class b common stock | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||||||||||||||
additional paid-in capital | 704,570,000 | 700,191,000 | 677,476,000 | 669,540,000 | 659,462,000 | 646,800,000 | 629,845,000 | 620,210,000 | 612,699,000 | 606,398,000 | 601,431,000 | 599,138,000 | |||||||||||||||||
retained earnings | 310,140,000 | 280,380,000 | 260,000,000 | 229,374,000 | 198,470,000 | 174,260,000 | 156,827,000 | 152,306,000 | 124,284,000 | 101,410,000 | 91,186,000 | 70,182,000 | |||||||||||||||||
statutory surplus reserve | 30,514,000 | 30,514,000 | 30,514,000 | 30,060,000 | 30,060,000 | 30,060,000 | 30,060,000 | 16,881,000 | 16,881,000 | 16,881,000 | 8,312,000 | 8,312,000 | |||||||||||||||||
accumulated other comprehensive loss | -58,781,000 | -61,946,000 | -63,372,000 | -40,815,000 | -54,830,000 | -54,925,000 | -49,349,000 | -60,354,000 | -61,916,000 | -32,768,000 | -3,415,000 | -2,623,000 | -3,077,000 | -1,168,000 | -200,000 | 827,000 | -109,000 | ||||||||||||
total acm research, inc. stockholders’ equity | 986,450,000 | 949,146,000 | 904,625,000 | 888,166,000 | 833,169,000 | 796,202,000 | 767,390,000 | 729,050,000 | 691,954,000 | 691,927,000 | 643,015,000 | 655,005,000 | 674,386,000 | 173,016,000 | 160,823,000 | 148,311,000 | 141,150,000 | 126,942,000 | 89,907,000 | 5,793,000 | |||||||||
non-controlling interests | 205,239,000 | 206,207,000 | 191,281,000 | 180,917,000 | 168,219,000 | 164,591,000 | 158,772,000 | 149,080,000 | 141,429,000 | 140,778,000 | 131,083,000 | 132,140,000 | 134,388,000 | 69,491,000 | 68,733,000 | 66,936,000 | 67,020,000 | 63,776,000 | 61,078,000 | 4,181,000 | |||||||||
total equity | 1,191,689,000 | 1,155,353,000 | 1,095,906,000 | 1,069,083,000 | 1,001,388,000 | 960,793,000 | 926,162,000 | 878,130,000 | 833,383,000 | 832,705,000 | 774,098,000 | 787,145,000 | |||||||||||||||||
total liabilities and equity | 2,039,715,000 | 1,933,768,000 | 1,855,721,000 | 1,794,175,000 | 1,667,575,000 | 1,556,749,000 | 1,490,908,000 | 1,410,248,000 | 1,316,914,000 | 1,312,751,000 | 1,147,666,000 | 1,071,524,000 | |||||||||||||||||
accounts receivable | 387,849,000 | 370,589,000 | 293,499,000 | 296,371,000 | 283,186,000 | 248,477,000 | 200,745,000 | 186,130,000 | 188,341,000 | 154,627,000 | |||||||||||||||||||
advances to related party | 1,384,000 | 1,024,000 | 1,453,000 | 2,756,000 | 1,338,000 | 2,432,000 | 1,164,000 | 1,155,000 | 2,306,000 | 5,158,000 | 3,073,000 | ||||||||||||||||||
related party accounts payable | 19,285,000 | 16,133,000 | 15,392,000 | 18,012,000 | 16,243,000 | 11,407,000 | 7,684,000 | 11,879,000 | 18,354,000 | 6,589,000 | 9,062,000 | ||||||||||||||||||
prepaid expenses | 7,507,000 | 10,794,000 | 18,594,000 | 20,066,000 | 20,023,000 | 17,540,000 | 18,970,000 | 19,319,000 | 17,771,000 | 18,851,000 | 21,771,000 | 7,531,000 | 8,953,000 | 5,917,000 | 5,892,000 | 5,531,000 | 3,157,000 | 1,985,000 | 1,006,000 | 1,547,000 | 1,833,000 | 1,985,000 | 2,142,000 | 2,316,000 | 2,383,000 | 546,000 | 801,000 | ||
land use right | 8,320,000 | 8,225,000 | 8,305,000 | 8,367,000 | 8,299,000 | 8,290,000 | 8,761,000 | 8,547,000 | 9,092,000 | 9,661,000 | 9,556,000 | 9,642,000 | 9,529,000 | 9,646,000 | 9,284,000 | ||||||||||||||
current portion of operating lease liability | 2,764,000 | 3,042,000 | 3,013,000 | 1,320,000 | 1,774,000 | 2,076,000 | 2,480,000 | 2,437,000 | 2,171,000 | 1,417,000 | 1,388,000 | 1,331,000 | 1,345,000 | 1,350,000 | 1,360,000 | 1,326,000 | |||||||||||||
long-term operating lease liability | 4,262,000 | 4,767,000 | 4,395,000 | 1,327,000 | 1,704,000 | 1,952,000 | 2,119,000 | 2,772,000 | 3,178,000 | 2,880,000 | 3,180,000 | 3,317,000 | 2,202,000 | 2,855,000 | 3,190,000 | 3,462,000 | |||||||||||||
trading securities | 6,375,000 | 12,733,000 | 14,164,000 | 23,894,000 | 25,772,000 | 30,219,000 | 31,257,000 | 27,003,000 | 28,239,000 | 23,888,000 | |||||||||||||||||||
income tax receivable | 63,000 | 1,521,000 | |||||||||||||||||||||||||||
deferred tax liability | 1,169,000 | 1,237,000 | 1,308,000 | 1,293,000 | 1,298,000 | 1,276,000 | 1,286,000 | ||||||||||||||||||||||
accumulated other comprehensive income | -57,920,000 | -22,633,000 | 10,979,000 | 5,759,000 | 5,931,000 | 3,961,000 | 4,857,000 | 1,037,000 | -857,000 | -955,000 | -209,000 | 122,000 | |||||||||||||||||
common stock | 5,000 | ||||||||||||||||||||||||||||
accounts receivables | 106,351,000 | 84,787,000 | 71,357,000 | 60,394,000 | 56,441,000 | 59,796,000 | 58,903,000 | 37,260,000 | 43,144,000 | 31,393,000 | 25,070,000 | 24,608,000 | 30,965,000 | 33,289,000 | 27,793,000 | 26,762,000 | 15,784,000 | ||||||||||||
income tax recoverable | 1,607,000 | ||||||||||||||||||||||||||||
liabilities and stockholders’ equity | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 150,000,000 shares authorized as of march 31, 2022 and december 31, 2021; 54,035,280 shares issued and outstanding as of march 31, 2022 and 53,608,929 shares issued and outstanding as of december 31, 2021 | 5,000 | ||||||||||||||||||||||||||||
common stock –class b, par value 0.0001: 5,307,816 shares authorized as of march 31, 2022 and december 31, 2021; 5,086,812 shares issued and outstanding as of march 31, 2022 and 5,087,814 shares issued and outstanding as of december 31, 2021 | 1,000 | ||||||||||||||||||||||||||||
additional paid in capital | 597,143,000 | 110,776,000 | 108,566,000 | 104,591,000 | 102,004,000 | 100,145,000 | 76,189,000 | 84,351,000 | 82,857,000 | 58,101,000 | 57,371,000 | 56,567,000 | 55,959,000 | 55,331,000 | 54,915,000 | 49,695,000 | 19,244,000 | ||||||||||||
accumulated surplus | 66,258,000 | 56,479,000 | 46,324,000 | 39,757,000 | 34,287,000 | 25,758,000 | 17,131,000 | 17,212,000 | 11,563,000 | 2,781,000 | |||||||||||||||||||
total stockholders’ equity | 808,774,000 | 242,507,000 | 229,556,000 | 215,247,000 | 208,170,000 | 190,718,000 | 150,985,000 | 98,942,000 | 91,345,000 | 59,715,000 | 55,642,000 | 52,324,000 | 49,332,000 | 45,597,000 | 43,002,000 | 39,857,000 | 9,974,000 | ||||||||||||
total liabilities and stockholders’ equity | 1,087,372,000 | 469,509,000 | 418,958,000 | 371,819,000 | 120,269,000 | 111,419,000 | 103,047,000 | 89,413,000 | 87,833,000 | 71,934,000 | |||||||||||||||||||
common stock – class a, par value 0.0001: 150,000,000 shares authorized as of september 30, 2021 and 50,000,000 shares authorized as of december 31, 2020; 17,798,740 shares issued and outstanding as of september 30, 2021 and 16,896,693 shares issued and outstanding as of december 31, 2020 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 5,307,816 shares authorized as of september 30, 2021 and 2,409,738 shares authorized as of december 31, 2020; 1,707,605 shares issued and outstanding as of september 30, 2021 and 1,802,606 shares issued and outstanding as of december 31, 2020 | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of june 30, 2021 and december 31, 2020; 17,668,409 shares issued and outstanding as of june 30, 2021 and 16,896,693 shares issued and outstanding as of december 31, 2020 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of june 30, 2021 and december 31, 2020; 1,707,605 shares issued and outstanding as of june 30, 2021 and 1,802,606 shares issued and outstanding as of december 31, 2020 | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of march 31, 2021 and december 31, 2020; 17,239,967 shares issued and outstanding as of march 31, 2021 and 16,896,693 shares issued and outstanding as of december 31, 2020 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of march 31, 2021 and december 31, 2020; 1,769,272 shares issued and outstanding as of march 31, 2021 and 1,802,606 shares issued and outstanding as of december 31, 2020 | |||||||||||||||||||||||||||||
liabilities, redeemable non-controlling interests and stockholders’ equity | |||||||||||||||||||||||||||||
redeemable non-controlling interests | 59,467,000 | 26,888,000 | |||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of december 31, 2020 and december 31, 2019; 16,896,693 shares issued and outstanding as of december 31, 2020 and 16,182,151 shares issued and outstanding as of december 31, 2019 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of december 31, 2020 and december 31, 2019; 1,802,606 shares issued and outstanding as of december 31, 2020 and 1,862,608 shares issued and outstanding as of december 31, 2019 | |||||||||||||||||||||||||||||
total liabilities, redeemable non-controlling interests, and stockholders’ equity | 341,257,000 | 296,619,000 | 257,402,000 | 217,208,000 | 180,216,000 | ||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of september 30, 2020 and december 31, 2019; 16,657,135 shares issued and outstanding as of september 30, 2020 and 16,182,151 shares issued and outstanding as of december 31, 2019 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of september 30, 2020 and december 31, 2019; 1,802,606 shares issued and outstanding as of september 30, 2020 and 1,862,608 shares issued and outstanding as of december 31, 2019 | |||||||||||||||||||||||||||||
financial liability carried at fair value | 15,147,000 | ||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of june 30, 2020 and december 31, 2019; 16,250,092 shares issued and outstanding as of june 30, 2020 and 16,182,151 shares issued and outstanding as of december 31, 2019 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of june 30, 2020 and december 31, 2019; 1,802,606 shares issued and outstanding as of june 30, 2020 and 1,862,608 shares issued and outstanding as of december 31, 2019 | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of march 31, 2020 and december 31, 2019; 16,317,346 shares issued and outstanding as of march 31, 2020 and 16,182,151 shares issued and outstanding as of december 31, 2019 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of march 31, 2020 and december 31, 2019; 1,862,608 shares issued and outstanding as of march 31, 2020 and december 31, 2019 | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of september 30, 2019 and december 31, 2018; 16,179,058 shares issued and outstanding as of september 30, 2019 and 14,110,315 shares issued and outstanding as of december 31, 2018 | 2,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of september 30, 2019 and december 31, 2018; 1,862,608 shares issued and outstanding as of september 30, 2019 and 1,898,423 shares issued and outstanding as of december 31, 2018 | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 50,000,000 shares authorized as of june 30, 2019 and december 31, 2018. 14,229,942 shares issued and outstanding as of june 30, 2019 and 14,110,315 shares issued and outstanding as of december 31, 2018 | 1,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 2,409,738 shares authorized as of june 30, 2019 and december 31, 2018. 1,883,423 shares issued and outstanding as of june 30, 2019 and 1,898,423 shares issued and outstanding as of december 31, 2018 | |||||||||||||||||||||||||||||
investment in affiliates, equity method | 1,476,000 | 1,360,000 | 1,472,000 | 1,355,000 | 1,238,000 | 1,237,000 | |||||||||||||||||||||||
common stock – class a, par value 0.0001: 100,000,000 shares authorized as of march 31, 2019 and december 31, 2018. 14,176,690 shares issued and outstanding as of march 31, 2019 and 14,110,315 shares issued and outstanding as of december 31, 2018 | 1,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 7,303,533 shares authorized as of march 31, 2019 and december 31, 2018. 1,898,423 shares issued and outstanding as of march 31, 2019 and 1,898,423 shares issued and outstanding as of december 31, 2018 | |||||||||||||||||||||||||||||
accumulated deficit | -1,530,000 | -3,387,000 | -5,673,000 | -9,526,000 | -12,741,000 | -9,961,000 | -13,344,000 | ||||||||||||||||||||||
other current assets | 32,000 | 45,000 | 46,000 | 890,000 | |||||||||||||||||||||||||
warrant liability | 3,079,000 | 3,033,000 | |||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 100,000,000 shares authorized as of december 31, 2018 and 2017. 14,110,315 shares issued and outstanding as of december 31, 2018 and 12,935,546 shares issued and outstanding as of december 31, 2017 | 1,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 7,303,533 shares authorized as of december 31, 2018 and 2017. 1,898,423 shares issued and outstanding as of december 31, 2018 and 2,409,738 shares issued and outstanding as of december 31, 2017 | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 100,000,000 shares authorized as of september 30, 2018 and december 31, 2017. 14,070,065 shares issued and outstanding as of september 30, 2018 and 12,935,546 shares issued and outstanding as of december 31, 2017 | 1,000 | ||||||||||||||||||||||||||||
common stock – class b, par value 0.0001: 7,303,533 shares authorized as of september 30, 2018 and december 31, 2017. 1,918,423 shares issued and outstanding as of september 30, 2018 and 2,409,738 shares issued and outstanding as of december 31, 2017 | |||||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 100,000,000 shares authorized as of june 30, 2018 and december 31, 2017. 13,957,339 shares issued and outstanding as of june 30, 2018 and 12,935,546 shares issued and outstanding as of december 31, 2017 | 1,000 | ||||||||||||||||||||||||||||
common stock–class b, par value 0.0001: 7,303,533 shares authorized as of june 30, 2018 and december 31, 2017. 1,920,173 shares issued and outstanding as of june 30, 2018 and 2,409,738 shares issued and outstanding as of december 31, 2017 | |||||||||||||||||||||||||||||
inventory | 19,865,000 | 15,388,000 | 18,077,000 | ||||||||||||||||||||||||||
common stock – class a, par value 0.0001: 100,000,000 shares authorized; 13,390,270 shares issued and outstanding as of march 31, 2018 and 12,935,546 shares issued and outstanding as of december 31, 2017 | 1,000 | ||||||||||||||||||||||||||||
common stock – class b, par value 0.0001: 7,303,533 shares authorized; 2,409,738 shares issued and outstanding as of march 31, 2018 and 2,409,738 shares issued and outstanding as of december 31, 2017 | 0 | ||||||||||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ equity | |||||||||||||||||||||||||||||
notes payable | 11,000 | 11,000 | |||||||||||||||||||||||||||
investors’ deposits | |||||||||||||||||||||||||||||
redeemable convertible preferred stock | |||||||||||||||||||||||||||||
series a: 385,000 shares authorized, no shares issued or outstanding as of december 31, 2017; 385,000 shares issued and outstanding as of december 31, 2016 | |||||||||||||||||||||||||||||
series b: 1,572,000 shares authorized, no shares issued or outstanding as of december 31, 2017; 1,572,000 issued and outstanding as of december 31, 2016 | |||||||||||||||||||||||||||||
series c: 1,360,962 shares authorized, no shares issued or outstanding as of december 31, 2017; 1,360,962 issued and outstanding as of december 31, 2016 (liquidation value of 0 and 2,041 at december 31,2017 and 2016). | |||||||||||||||||||||||||||||
series d: 2,659,975 shares authorized, no shares issued or outstanding as of december 31, 2017; 1,326,642 shares issued and outstanding as of december 31, 2016 | |||||||||||||||||||||||||||||
series e: 10,718,530 shares authorized, no shares issued or outstanding as of december 31, 2017 and 2016 | |||||||||||||||||||||||||||||
series f: 6,000,000 shares authorized, no shares issued or outstanding as of december 31, 2017; 3,663,254 issued and outstanding as of december 31, 2016 | |||||||||||||||||||||||||||||
total redeemable convertible preferred stock | 23,834,000 | ||||||||||||||||||||||||||||
stockholders’ equity | |||||||||||||||||||||||||||||
common stock – class a, with par value 0.0001: 100,000,000 shares authorized, 12,935,546 shares issued and outstanding as of december 31, 2017; 100,000,000 shares authorized and 2,228,740 shares issued and outstanding as of december 31, 2016 | 1,000 | ||||||||||||||||||||||||||||
common stock – class b, with par value 0.0001: 7,303,533 shares authorized and 2,409,738 shares issued and outstanding as of december 31, 2017 and 2016 | |||||||||||||||||||||||||||||
total acm research, inc. stockholders’ (deficit) equity | 39,857,000 | ||||||||||||||||||||||||||||
total liabilities, redeemable convertible preferred stock and stockholders’ equity | 67,891,000 | 61,056,000 | |||||||||||||||||||||||||||
loans receivable – related party | 946,000 | ||||||||||||||||||||||||||||
investment in equity method affiliates | 1,220,000 | ||||||||||||||||||||||||||||
investors’ deposit | |||||||||||||||||||||||||||||
income tax payable | 44,000 | ||||||||||||||||||||||||||||
series a: 385,000 shares authorized, issued and outstanding as of september 30, 2017 and december 31, 2016 (liquidation value of 308 at september 30, 2017 and december 31, 2016); and no shares authorized, issued or outstanding pro forma as of september 30, 2017 | 288,000 | ||||||||||||||||||||||||||||
series b: 1,572,000 shares authorized, issued and outstanding as of september 30, 2017 and december 31, 2016 (liquidation value of 1,572 at september 30, 2017 and december 31, 2016) and no shares authorized, issued or outstanding pro forma as of september 30, 2017 | 1,572,000 | ||||||||||||||||||||||||||||
series c: 1,360,962 shares authorized, issued and outstanding as of september 30, 2017 and december 31, 2016 (liquidation value of 2,041 at september 30, 2017 and december 31, 2016); and no shares authorized, issued or outstanding, pro forma as of september 30, 2017 | 2,041,000 | ||||||||||||||||||||||||||||
series d: 2,659,975 shares authorized and 1,326,642 shares issued and outstanding as of september 30, 2017 and december 31, 2016 (liquidation value of 4,975 at september 30, 2017 and december 31, 2016); and no shares authorized, issued or outstanding, pro forma as of september 30, 2017 | 4,975,000 | ||||||||||||||||||||||||||||
series e: 10,718,530 shares authorized, 4,998,508 shares issued and outstanding as of september 30, 2017 (liquidation value of 4,999 at september 30, 2017); and no shares authorized, issued or outstanding as of december 31, 2016 and pro forma as of september 30, 2017 | 5,800,000 | ||||||||||||||||||||||||||||
series f: 6,000,000 shares authorized, 3,663,254 shares issued and outstanding as of september 30, 2017 and december 31, 2016 (liquidation value of 9,158 at september 30, 2017 and december 31, 2016); and no shares authorized, issued or outstanding pro forma as of september 30, 2017 | 9,158,000 | ||||||||||||||||||||||||||||
common stock – class a, with par value 0.0001: 100,000,000 shares authorized, 4,741,635 shares issued and outstanding as of september 30, 2017; 100,000,000 shares authorized and 2,228,740 shares issued and outstanding as of december 31, 2016; 100,000,000 shares authorized and 9,369,212 shares issued and outstanding pro forma as of september 30, 2017 | 1,000 | ||||||||||||||||||||||||||||
common stock – class b, with par value 0.0001: 7,303,533 shares authorized and 2,409,738 shares issued and outstanding as of september 30, 2017 and december 31, 2016; and 7,303,533 shares authorized and 2,409,738 shares issued and outstanding pro forma as of september 30, 2017 | 1,000 |
We provide you with 20 years of balance sheets for ACM Research stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ACM Research. Explore the full financial landscape of ACM Research stock with our expertly curated balance sheets.
The information provided in this report about ACM Research stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.